Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Robert Brodell MD, FAAD

Robert T. Brodell MD, FAAD

Professor and Chair, Department of Pathology; Past Founding Chair, Department of Dermatology; Billy S. Guyton Distinguished Professor, University of Mississippi Medical Center, Jackson, Mississippi

After founding the Department of Dermatology at the University of Mississippi Medical Center in 2013, Dr. Robert T. Brodell is now tenured Professor and Chair of the Department of Pathology. His research focuses on human papillomavirus and translational research — moving science to the treatment room. His clinical interests include general dermatology, procedural dermatology, dermatopathology, and warts. In addition to his involvement in teaching, he has a strong interest in the ethics of dermatology, in tips and tricks for procedural dermatology, and in access to care in rural America. He also serves as a part-time staff physician at the Sonny Montgomery Veterans Administration Hospital in Jackson, Mississippi.

A dedicated teacher, he has performed almost 2000 lectures in his career and is the recipient of the Thomas G. Pearson, EdD, Memorial Education Award of the American Academy of Dermatology in 2018. He is also a dedicated volunteer for the American Cancer Society and a member of the Relay For Life Hall of Fame.

Dr. Brodell is an associate editor of the Journal of the American Academy of Dermatology, and he serves on the editorial boards of the American Medical Student Research Journal, where he is faculty advisor to the editorial board, Practical Dermatology, Journal of the Mississippi State Medical Society, and SKIN: The Journal of Cutaneous Medicine.

Disclosures

  • Multicenter clinical trials: Novartis (principal investigator); CorEvitas (psoriasis biologic registry)
  • Educational grant: Pfizer

Recent Contributions to PracticeUpdate:

  1. Comparison of 10% Potassium Hydroxide Solution Versus Cryotherapy in the Treatment of Molluscum Contagiosum: An Open Randomized Clinical Trial
  2. 8 Changes I Made in My Clinical Practice in 2013
  3. Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States: Findings From the National Psoriasis Foundation Surveys, 2003-2011
  4. FDA Drug Safety Communication: FDA Limits Usage of Nizoral (Ketoconazole) Oral Tablets Due to Potentially Fatal Liver Injury and Risk of Drug Interactions and Adrenal Gland Problems
  5. FDA Drug Safety Communication: FDA Limits Usage of Nizoral (Ketoconazole) Oral Tablets Due to Potentially Fatal Liver Injury and Risk of Drug Interactions and Adrenal Gland Problems
  6. Bullous Pemphigoid as Pruritus in the Elderly: A Common Presentation
  7. Daily Sunscreen Use (> SPF 15) and Regular Reapplication Significantly Retarded Photoaging of the Skin
  8. Elderly Patients With Multiple Prurigo Nodules in Sun-Damaged Skin May Be Predisposed to Keratoacanthoma
  9. Vanity, Not Fear, Drives Sunscreen Use in Teens
  10. Study Indicates IM TAC is Safe, Effective Treatment for Steroid-Responsive Dermatoses

Most Read This Week

Recently Updated